The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: The results of a double blind, placebo controlled, multicenter clinical trial

Studies in the 1970s and 1980s reported that bacterial lysates (BL) had a prophylactic effect on recurrent respiratory tract infections (RRTI). However, controlled clinical study procedures have evolved substantially since then. We performed a trial using updated methods to evaluate the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Braido, Fulvio, Melioli, Giovanni, Candoli, Piero, Cavalot, Andrea, Di Gioacchino, Mario, Ferrero, Vittorio, Incorvaia, Cristoforo, Mereu, Carlo, Ridolo, Erminia, Rolla, Giovanni, Rossi, Oliviero, Savi, Eleonora, Tubino, Libero, Reggiardo, Giorgio, Baiardini, Ilaria, di Marco, Eddi, Rinaldi, Gilberto, Canonica, Giorgio Walter, Accorsi, Carlo, Bossilino, Claudia, Bonzano, Laura, DiLizia, Michela, Fedrighini, Barbara, Garelli, Valentina, Gerace, Vincenzo, Maniscalco, Sara, Massaro, Ilaria, Messi, Alessandro, Milanese, Manlio, Peveri, Silvia, Penno, Arminio, Pizzimenti, Stefano, Pozzo, Tiziana, Raie, Alberto, Regina, Sergio, Sclifò, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173099/
https://www.ncbi.nlm.nih.gov/pubmed/25445613
http://dx.doi.org/10.1016/j.imlet.2014.10.026

Ejemplares similares

Ejemplares similares